Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
LY294002: From PI3K Mechanism to ESCC Translation
2026-09-20
LY294002 offers a reversible way to interrogate PI3K/Akt/mTOR signaling in cancer models, but its translational value depends on disciplined controls for pathway specificity, macrophage biology, apoptosis, and autophagy. This article connects the SPP1–CD44–PI3K/AKT axis identified in oesophageal squamous cell carcinoma with practical experimental strategy while defining the limits of pharmacological inference.
-
BMS 309403: Interpreting FABP4 Biology
2026-09-19
BMS 309403 is a potent FABP4 inhibitor for dissecting lipid handling, macrophage inflammation, and foam-cell biology. This article goes beyond a standard workflow by showing how to separate target engagement from pathway-level and disease-relevant interpretation.
-
Sumatriptan’s Anti-Inflammatory Evidence
2026-09-18
This systematic review reframes sumatriptan from a migraine therapy as a candidate modulator of inflammation-related signaling. By synthesizing receptor, cytokine, nitric oxide, CGRP, and tissue-injury evidence, it identifies a translational hypothesis while also highlighting the limits of heterogeneous preclinical data.
-
EZH2, Autophagy, and Neuropathic Pain After BPA
2026-09-18
The reference study identifies an EZH2–mTOR–autophagy pathway in anterior cingulate cortex microglia that intensifies neuropathic pain after brachial plexus avulsion. Its findings connect epigenetic regulation with neuroinflammation and suggest that restoring microglial autophagy may reduce pain-related hypersensitivity, while also highlighting important limits for translation beyond the rat model.
-
Measuring HOXC9-Driven Apoptosis in ESCC
2026-09-17
A translational framework for connecting HOXC9, AKT/mTOR signaling, and mitochondria-dependent apoptosis in esophageal squamous cell carcinoma using dual-parameter Annexin V and PI analysis.
-
FPS-ZM1: From RAGE Biology to Brain Assays
2026-09-17
FPS-ZM1 is a selective RAGE inhibitor for dissecting amyloid beta (Aβ) signaling, blood-brain barrier transport, and neuroinflammation. This article translates new RAGE/POMC findings into a rigorous, brain-focused assay strategy while separating mechanistic evidence from therapeutic interpretation.
-
Tivozanib: Measure More Than Cell Viability
2026-09-16
Tivozanib (AV-951) is a selective VEGFR inhibitor whose research value depends on measuring both growth suppression and cell killing. This endpoint-first guide integrates molecular pharmacology with assay design to improve interpretation of renal cell carcinoma and combination-treatment studies.
-
NU7441 (KU-57788) in DNA Repair Research
2026-09-16
NU7441 (KU-57788) is a selective ATP-competitive DNA-PK inhibitor for linking DNA damage response signaling to measurable cell-cycle and cytotoxicity phenotypes. This guide translates its reported potency, formulation requirements, and combination use into practical workflows for DNA repair research, oncology research, and cancer research.
-
Hypoxia, S100A10, and GBM Chemoresistance
2026-09-15
The reference study identifies hypoxia-induced S100A10 as a functional driver of glioblastoma proliferation, glycolysis, apoptosis suppression, and temozolomide resistance through PI3K-AKT signaling. Its integrated use of public datasets, molecular assays, metabolic measurements, and cell-death analysis provides a mechanistic framework for studying hypoxic GBM biology.
-
5X Protein Loading Buffer (Reducing) Guide
2026-09-15
5X Protein Loading Buffer (Reducing) standardizes protein sample preparation for conventional SDS-PAGE by combining SDS, a sulfhydryl reducing agent, buffer salts, and tracking dye. Use it when denaturing and reducing conditions are required for protein molecular weight separation; do not use it when native structure or non-reducing disulfide states must be preserved.
-
Lipid Nanoparticle Trafficking and Endosomal Escape
2026-09-14
This study shows that lipid nanoparticle uptake is not equivalent to productive intracellular delivery: excessive internalization can trap particles in peripheral endosomes and reduce cytosolic release. By combining sensitive LNP labeling with controlled endolysosomal states, the work identifies nutrient-dependent activity, perinuclear trafficking, and continuous internalization as linked determinants of transgene expression.
-
EV-Transferred ACLY Reprograms TAMs in HCC
2026-09-14
The reference study identifies extracellular-vesicle transfer of ATP-citrate lyase (ACLY) as a metabolic mechanism that directs monocytes toward immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. Its engineered CD81-decorated liposomal vesicles provide a useful causal framework for studying targeted metabolic reprogramming and improving anti-PD-1/PD-L1 responses.
-
Intestinal Stretch, Obesity, and Weight-Loss Recovery
2026-09-13
The reference study shows that intestinal stretch, independent of classical GLP-1 signaling, acutely suppresses feeding and improves oral glucose tolerance in mice. Obesity weakens this gut–brain response, whereas dietary and surgical weight loss restore intestinal stretch sensitivity and nucleus of the solitary tract activation.
-
AO/PI Staining Solution for Viability Workflows
2026-09-12
AO/PI Staining Solution enables fluorescence-based cell counting that separates nucleated cells with intact membranes from membrane-compromised cells, debris, and red blood cell interference. This article translates the approach into practical workflows for podocyte injury, diabetic nephropathy studies, cytotoxicity screens, and other complex samples.
-
Biotin-tyramide: Practical TSA Workflow Guide
2026-09-11
Biotin-tyramide (SKU A8011) supports HRP-driven tyramide signal amplification when conventional immunohistochemistry or in situ hybridization signals are too weak for reliable imaging. It is intended for research workflows using fixed cells or tissue sections and should not be treated as a diagnostic reagent or a universal substitute for non-HRP labeling systems.